Aspartate--tRNA ligase, cytoplasmic (DARS)

The protein contains 501 amino acids for an estimated molecular weight of 57136 Da.

 

Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. (updated: April 1, 2015)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Lange and co-workers. (2014) Annotating N termini for the human proteome project: N termini and Nα-acetylation status differentiate stable cleaved protein species from degradation remnants in the human erythrocyte proteome. J Proteome Res. 13(4), 2028-2044.
  3. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  4. Wilson and co-workers. (2016) Comparison of the Proteome of Adult and Cord Erythroid Cells, and Changes in the Proteome Following Reticulocyte Maturation. Mol Cell Proteomics. 15(6), 1938-1946.
  5. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.
  6. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.
  7. Chu and co-workers. (2018) Quantitative mass spectrometry of human reticulocytes reveal proteome-wide modifications during maturation. Br J Haematol. 180(1), 118-133.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

Interpro domains
Total structural coverage: 100%
Model score: 100
No model available.

(right-click above to access to more options from the contextual menu)

VariantDescription
HBSL
HBSL
HBSL
dbSNP:rs1803165
HBSL
HBSL
HBSL
HBSL
HBSL

The reference OMIM entry for this protein is 603084

Aspartyl-trna synthetase; dars
Asprs

DESCRIPTION

The DARS gene encodes cytoplasmic aspartyl-tRNA synthetase. Aminoacyl-tRNA synthetases constitute a family of enzymes catalyzing the specific aminoacylation of cognate tRNA in the initial step of ribosome-dependent protein biosynthesis. Mammalian synthetases differ from those of prokaryotes and lower eukaryotes in that they associate as multienzyme complexes (summary by Jacobo-Molina et al., 1989).

CLONING

By screening a HeLa cell cDNA library with a rat Dars cDNA cloned by them, Jacobo-Molina et al. (1989) isolated a cDNA encoding DARS. The predicted DARS protein has 500 amino acids and a calculated molecular mass of 57,000 Da. The human DARS protein has 95% amino acid identity with rat Dars and shares unevenly distributed identity with yeast aspartyl-tRNA synthetase, with 69% identity at the C-terminal half and 46% identity at the N-terminal half. The authors discussed several potential functional domains in the DAR protein, including a region of conserved lysine residues which is also found in bacterial and yeast synthetases and is likely to be the binding site for the 3-prime end of tRNA, a nucleotide triphosphate-binding motif, an ATP-binding motif with strong similarity to that present in E. coli alanyl-tRNA synthetase, and a cyclic AMP-dependent protein kinase phosphorylation site. Jacobo-Molina et al. (1989) predicted a neutral amphiphilic helix at the N-terminal end of the DARS protein and stated that this structure does not occur in other known synthetases from bacteria, yeast, and higher organisms. Based on a curated set of publicly available data, Taft et al. (2013) found that Dars is diffusely localized in the cytoplasm and broadly expressed across tissue types, including the central nervous system. In mice, Dars showed specific expression in neurons of the hippocampus, the dentate gyrus, and the molecular layer of the cerebellum. DARS expression in the developing and adult human brain showed a similar pattern, with preferential immunostaining of neurons in the cerebellum, cerebral cortex, hippocampus, and lateral ventricle. In addition, staining of peripheral neurons was evident in the colon. Lo et al. (2014) reported the discovery of a large number of natural catalytic nulls for each human aminoacyl tRNA synthetase. Splicing events retain noncatalytic domains while ablating the catalytic domain to create catalytic nulls with diverse functions. Each synthetase is converted into several new signaling proteins with biologic activities 'orthogonal' to that of the catalytic parent. The recombinant aminoacyl tRNA synthetase variants had specific biologic activities across a spectrum of cell-based assays: about 46% across all species affect transcriptional regulation, 22% cell differentiation, 10% immunomodulation, 10% cytoprotection, and 4% each for proliferation, adipogenesis/cholesterol transport, and inflammatory response. Lo et al. (2014) identified in-frame splice variants of cytoplasmic aminoacyl tRNA synthetases. They identified 4 catalytic-null and 1 catalytic domain-retained splice variants for AspRS.

MAPPING

Gross (2012) mapped the DARS gene to chromosome 2q21.3 based on an alignment of the DARS sequence (GenBank GENBANK BC000629) with the genomic sequence (GRCh37).

MOLECULAR GENETICS

In 10 patients from 7 unrelated families of various origins with hypomyelination with brainstem and spinal cord involvement and spasticity (HBSL; 615281), Taft et al. (2013) identif ... More on the omim web site

Subscribe to this protein entry history

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 603084 was added.

Jan. 27, 2016: Protein entry updated
Automatic update: model status changed

Jan. 24, 2016: Protein entry updated
Automatic update: model status changed